Chemo-free Smart Start regimen looks promising in poor-prognosis DLBCLJune 7, 2019Lymphoma & Plasma Cell Disorders
Fixed-duration venetoclax-obinutuzumab superior to standard CLL therapyJune 7, 2019Leukemia, Myelodysplasia, TransplantationHematology
Laparoscopic surgery survival outcomes on par with open approach in colorectal liver metastasesJune 3, 2019Oncology
Targeted sequencing panel IDs Lynch syndrome in women with/at risk for endometrial cancerMay 22, 2019Oncology
Lenalidomide may reduce risk of progression from SMM to MMMay 16, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersHematology
Ultrasound offers advantages for long-term lymph node surveillance in high-grade SCC patientsMay 8, 2019Head & Neck/Thyroid CancersOncology
Neoadjuvant removal of DCIS helps identify HER2+ nonsurgical trial candidatesMay 8, 2019Breast Cancer
Researchers propose new risk groups for NK-AMLMay 8, 2019AMLLeukemia, Myelodysplasia, TransplantationHematology
SRA737 + anti–PD-L1 therapy and low-dose gemcitabine shows early promise for SCLCApril 30, 2019Lung Cancer
